| MREFX | VEURX | MREFX / VEURX | |
| Total Expense Ratio | 1.36 | 0.24 | 567% |
| Annual Report Gross Expense Ratio | 1.95 | 0.24 | 813% |
| Fund Existence | 23 years | 36 years | - |
| Gain YTD | 3.696 | 31.029 | 12% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 100 | 0 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 112M | 35.8B | 0% |
| Annual Yield % from dividends | 2.45 | 2.71 | 91% |
| Returns for 1 year | 1.21 | 24.80 | 5% |
| Returns for 3 years | 29.39 | 47.22 | 62% |
| Returns for 5 years | 22.90 | 41.80 | 55% |
| Returns for 10 years | 53.60 | 74.88 | 72% |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| DFSV | 34.10 | 0.28 | +0.83% |
| Dimensional US Small Cap Value ETF | |||
| BSJS | 22.04 | 0.02 | +0.09% |
| Invesco BulletShares 2028 HY Corp Bd ETF | |||
| IDNA | 26.69 | 0.01 | +0.04% |
| iShares Genomics Immnlgy & Hlthcr ETF | |||
| TPLE | 27.74 | N/A | N/A |
| Timothy Plan US Large/Mid CAP Core Enhanced ETF | |||
| EMOT | 24.21 | N/A | N/A |
| First Trust S&P 500 Economic Moat ETF | |||